Pharma firm files cyberlibel complaint vs. Dr. Tony Leachon

A Pharmaceutical company on Tuesday filed a cyberlibel complaint against health expert Dr. Tony Leachon before the National Bureau of Investigation (NBI).

According to Mark Makalalad’s report on Super Radyo dzBB, Bell-Kenz Pharma Inc. officials filed a complaint against Leachon over his allegations that the pharmaceutical company hands out luxury items to doctors for them to prescribe its products.

Bell-Kenz Pharma Chief Executive Officer Luis Raymond Go has dismissed the allegation and described it as “misinformation” during a Senate hearing held last week. 

“I unequivocally state that Bell-Kenz is a law-abiding company adhering to the rules of the Food and Drug Administration (FDA), the Securities and Exchange Commission (SEC), the Philippine Medical Association (PMA), and other relevant governing bodies,” said Go during the hearing.

Press Statement: Dr. Tony Leachon**
Cyber Libel case

I have been informed that Bell-Kenz Pharma Inc., which is under Senate inquiry for possible ethical violations in the medical field, has initiated a cyber libel case against me.

While my legal team and I are currently…

— Tony Leachon MD (@DrTonyLeachon) May 21, 2024

Meanwhile, Leachon said he and his legal team is reviewing the details of the complaint, which he described as an "attempt to redirect the narrative and intimidate the critics.”

"The basis of my comments regarding the issue manifests my concern for the integrity of the medical profession," said Leachon.

“I stand by my decision to bring these matters to public attention. It is crucial that such issues are debated openly for the sake of our medical community and the trust that the Filipino people place in their healthcare providers,” he added. —VAL, GMA Integrated News